Syllabus: Science and Technology- developments and their applications and effects in everyday life.
Background
- Global shift toward cleaner manufacturing is accelerating demand for biomaterials in multiple sectors.
- Biomaterials are emerging as a key frontier in materials engineering for low-carbon transitions.
What are Biomaterials?
- Biomaterials are materials derived partly or wholly from biological sources or processes.
- They are designed to replace or interact with conventional petroleum-based materials.
- Used across packaging, textiles, construction, and healthcare industries.
- Drop-in biomaterials are chemically identical to fossil materials and fit existing systems.
- Example includes bio-PET, usable without changing current manufacturing infrastructure.
- Drop-out biomaterials differ chemically and require new processing or disposal systems.
- Examples include polylactic acid (PLA) requiring composting or specialised recycling.
- Novel biomaterials offer new properties like self-healing, bioactivity, or advanced composites.
Why Biomaterials Matter for India
- Biomaterials support environmental sustainability, industrial growth, and revenue generation simultaneously.
- Indigenous biomanufacturing reduces dependence on fossil-based imports for plastics and chemicals.
- Agricultural residues and feedstocks offer diversified farmer income beyond food markets.
- Aligns Indian exports with global low-carbon and circular economy regulations.
- Supports domestic priorities like single-use plastic bans and climate commitments.
India’s Current Position
- India’s biomaterials sector includes bioplastics, biopolymers, and bio-derived materials.
- Bioplastics market valued at $500 million in 2024, with strong growth projections.
- Some segments still depend on foreign technologies for feedstock-to-product conversion.
Way Forward
- Scaling must avoid food-feedstock competition, water stress, and soil degradation.
- Weak waste management and composting infrastructure could dilute environmental benefits.
- Fragmented policy coordination risks slowing adoption and increasing import dependence.
- Priorities include scaling biomanufacturing infrastructure, improving feedstock productivity, and R&D investment.
- Clear regulatory definitions, labelling norms, and end-of-life pathways are essential.
- Government procurement, incentives, and shared pilot facilities can de-risk early investments.